Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Free Cash Flow (2019 - 2025)

Quantum Biopharma's Free Cash Flow history spans 6 years, with the latest figure at -$305598.0 for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 63.43% to -$305598.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.2 million, a 19.79% decrease, with the full-year FY2025 number at -$8.2 million, down 19.79% from a year prior.
  • Free Cash Flow hit -$305598.0 in Q4 2025 for Quantum Biopharma, up from -$1.7 million in the prior quarter.
  • Over the last five years, Free Cash Flow for QNTM hit a ceiling of $9.4 million in Q2 2022 and a floor of -$50.6 million in Q4 2022.
  • Historically, Free Cash Flow has averaged -$4.0 million across 4 years, with a median of -$721122.0 in 2024.
  • Biggest five-year swings in Free Cash Flow: soared 345.25% in 2021 and later plummeted 221.38% in 2025.
  • Tracing QNTM's Free Cash Flow over 4 years: stood at -$37.4 million in 2021, then plummeted by 35.21% to -$50.6 million in 2022, then soared by 98.35% to -$835762.0 in 2024, then soared by 63.43% to -$305598.0 in 2025.
  • Business Quant data shows Free Cash Flow for QNTM at -$305598.0 in Q4 2025, -$1.7 million in Q3 2025, and -$1.9 million in Q2 2025.